mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.8 |
mRNA |
EX-527 |
GDSC1000 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.8 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.8 |